Otorhinolaryngologic disease
MONDO:0024623Pathological processes of the ear, the nose, and the throat, also known as the ENT diseases.
Also known as: ear, nose and throat disorder, ear, nose or throat disorder, ear/nose/throat disease, otolaryngologic disorder, otorhinolaryngologic disease, ENT disease, ENT diseases, disease, ENT
1319 clinical trials for this condition and its sub-types, 15 tagged with Otorhinolaryngologic disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Otorhinolaryngologic disease
-
Disorder of pharynx 3 trials · 596 incl. sub-types
10 sub-types
- Pharynx cancer 10 trials · 495 incl. sub-types Sub-types →
- Neoplasm of oropharynx 3 trials · 279 incl. sub-types Sub-types →
- Nasopharyngeal disorder 1 trial · 263 incl. sub-types Sub-types →
- Neoplasm of hypopharynx 0 trials · 100 incl. sub-types Sub-types →
- Takayasu arteritis 27 trials
- Tonsillitis 23 trials · 27 incl. sub-types Sub-types →
- Tonsil neoplasm 0 trials · 8 incl. sub-types Sub-types →
- Peritonsillar abscess 4 trials
- Epiglottitis 1 trial Sub-types →
- Oropharyngeal anthrax 0 trials
-
Nasal disorder 3 trials · 372 incl. sub-types
5 sub-types
- Nasal cavity disorder 3 trials · 224 incl. sub-types Sub-types →
- Paranasal sinus disorder 12 trials · 162 incl. sub-types Sub-types →
- Anosmia 35 trials Sub-types →
- Nasal cavity and paranasal sinus lethal midline granuloma 0 trials
- Nasal dermoid cyst 0 trials
-
Disorder of ear 8 trials · 254 incl. sub-types
6 sub-types
- Inner ear disorder 8 trials · 149 incl. sub-types Sub-types →
- Middle ear disorder 3 trials · 75 incl. sub-types Sub-types →
- Ear infection 9 trials · 40 incl. sub-types Sub-types →
- External ear disorder 0 trials · 13 incl. sub-types Sub-types →
- Hyperacusis 10 trials Sub-types →
- Ear neoplasm 0 trials · 3 incl. sub-types Sub-types →
-
Lip and oral cavity squamous cell carcinoma 21 trials · 157 incl. sub-types
1 sub-type
- Oral cavity squamous cell carcinoma 139 trials · 154 incl. sub-types Sub-types →
-
Hereditary otorhinolaryngologic disease 0 trials · 102 incl. sub-types
21 sub-types
- X-linked mixed hearing loss with perilymphatic gusher 32 trials
- Benign paroxysmal positional vertigo 18 trials
- Meniere disease 16 trials Sub-types →
- Motion sickness 14 trials · 16 incl. sub-types Sub-types →
- Familial congenital nasolacrimal duct obstruction 7 trials
- Choanal atresia 4 trials Sub-types →
- Otosclerosis 4 trials Sub-types →
- Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome 2 trials
- Familial thyroglossal duct cyst 2 trials
- BNAR syndrome 1 trial
- Aural atresia, congenital 1 trial
- Second branchial cleft anomaly 1 trial
- Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome 1 trial
- X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome 0 trials
- Bifid nose, autosomal recessive 0 trials Sub-types →
- Familial nasal acilia 0 trials
- Isolated congenital anosmia 0 trials
- Nasal dermoid cyst 0 trials
- Tonsillar lymphoma 0 trials
- Tympanic paraganglioma 0 trials
- Vertigo, benign recurrent, 1 0 trials
-
Idiopathic bilateral vestibulopathy 14 trials
-
Laryngeal abductor paralysis 10 trials
-
Recurrent respiratory papillomatosis 8 trials · 9 incl. sub-types
1 sub-type
- Laryngeal papillomatosis 1 trial
-
Microtia 8 trials
1 sub-type
- Ear without helix 0 trials
-
Congenital tracheomalacia 6 trials
-
Autoimmune disease of ear, nose and throat 0 trials · 4 incl. sub-types
7 sub-types
- Autoimmune inner ear disease 2 trials
- Autoimmune uveitis 2 trials
- Cogan syndrome 0 trials
- IgG4-related dacryoadenitis and sialadenitis 0 trials
- IgG4-related submandibular gland disease 0 trials
- Autoimmune retinopathy 0 trials
- Eosinophilic angiocentric fibrosis 0 trials
-
Cysts and fistulae of the face and oral cavity 0 trials · 3 incl. sub-types
13 sub-types
- Familial thyroglossal duct cyst 2 trials
- First branchial cleft anomaly 1 trial
- Second branchial cleft anomaly 1 trial
- Cervical dermoid cyst 0 trials
- Cervicofacial fibrochondroma 0 trials
- Commissural lip fistula 0 trials
- Digestive duplication cyst of the tongue 0 trials
- Facial dermoid cyst 0 trials Sub-types →
- Fourth branchial cleft anomaly 0 trials
- Lower lip fistula 0 trials
- Nasal dorsum fistula/cyst 0 trials
- Pinnae fistula or cyst 0 trials
- Third branchial cleft anomaly 0 trials
-
Mal de Debarquement 2 trials
-
Anotia 1 trial
-
Bifid nose 0 trials · 1 incl. sub-types
3 sub-types
- BNAR syndrome 1 trial
- Bifid nose, autosomal dominant 0 trials
- Bifid nose, autosomal recessive 0 trials Sub-types →
-
Arrhinia 0 trials
-
Congenital tracheal stenosis 0 trials
-
Epignathus 0 trials
-
Isolated congenital syngnathia 0 trials
-
Laryngeal neuroendocrine neoplasm 0 trials
1 sub-type
- Laryngeal small cell carcinoma 0 trials
-
Laryngotracheal angioma 0 trials
-
Larynx atresia 0 trials
-
Middle ear anomaly 0 trials
3 sub-types
-
Nasal encephalocele 0 trials
-
Nasal ganglioglioma 0 trials
-
Nasal glial heterotopia 0 trials
-
Nasolacrimal duct cyst 0 trials
-
Polyrrhinia 0 trials
-
Proboscis lateralis 0 trials
-
Silent sinus syndrome 0 trials
-
Supernumerary nostril 0 trials
-
Supratip dysplasia 0 trials
-
Tracheal agenesis 0 trials
Most studied deeper sub-types
-
Ear drops after tube surgery: do they prevent blockage?
Disease control Stopped earlyThis study looked at whether using antibiotic ear drops during and after ear tube surgery reduces the chance of tube blockage or ear drainage in children. Only 9 children took part, and each child received drops in one ear but not the other. The study was stopped early, so the fi…
Phase 4 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New combo aims to boost immune attack on HPV-Driven head and neck cancer
Disease control Stopped earlyThis Phase 3 trial tests whether adding an experimental immunotherapy called PDS0101 to the standard drug pembrolizumab helps people with advanced HPV16-positive head and neck cancer live longer. About 252 participants will receive either the combination or pembrolizumab alone. T…
Phase 3 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can an antiviral drug protect hearing in infants with congenital CMV?
Disease control Stopped earlyThis trial tests whether the antiviral drug valganciclovir can improve hearing and language outcomes in infants who have hearing loss due to congenital cytomegalovirus (CMV) infection. Infants aged 1 to 12 months with confirmed sensorineural hearing loss will receive either valga…
Phase 2 • Sponsor: Albert Park • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Experimental cell therapy takes on stubborn autoimmune diseases
Disease control Stopped earlyThis early study tested a new cell therapy called LUCAR-G79 in just 3 adults with severe autoimmune diseases that did not respond to standard treatments. The therapy uses specially engineered immune cells to target and potentially calm the overactive immune system. The main goals…
Phase 1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Tooth-Related sinusitis study halted early – results uncertain
Disease control Stopped earlyThis study looked at whether treating the dental cause of chronic maxillary sinusitis with dental procedures and medication could resolve symptoms. Only 16 patients were enrolled before the study was terminated. The main goal was to see if symptoms disappeared and pus cleared fro…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental combo therapy shows promise in advanced cancers, but trial halted early
Disease control Stopped earlyThis study tested whether injecting vidutolimod directly into tumors plus giving cemiplimab through a vein could shrink cancers that have spread. The trial included 77 people with several types of advanced cancer. Unfortunately, the study was stopped early, so we have less inform…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New cocktail of cancer drugs tested in desperate cases
Disease control Stopped earlyThis early-phase trial tested combinations of the drugs bevacizumab and temsirolimus, sometimes with valproic acid or cetuximab, in 154 people with advanced cancers or certain non-cancerous but progressive diseases. The main goal was to find safe doses and look for any signs that…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Tonsil infection showdown: surgery vs. drainage
Disease control Stopped earlyThis study looked at the best way to treat a tonsillar abscess, a painful infection near the tonsils. It compared two treatments: removing the tonsils (tonsillectomy) versus draining the pus with a needle under local anesthesia. The goal was to see which method works better to cl…
Sponsor: University Hospital, Geneva • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Promising combo for HPV throat cancer hits snag: trial stopped early
Disease control Stopped earlyThis study looked at adding two immunotherapy drugs (ipilimumab and nivolumab) to standard radiation for people with advanced HPV-positive throat cancer. The goal was to see if the combination was safe and could shrink tumors better than radiation alone. The trial enrolled 37 par…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can a steroid spray break the decongestant habit?
Disease control Stopped earlyThis small, early-stage trial tested a combination of a steroid spray (triamcinolone) and a decongestant spray (oxymetazoline) to help people who were dependent on decongestants stop using them. The study planned to slowly reduce the decongestant dose while keeping the steroid st…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Immune cell therapy tested for tough childhood cancers
Disease control Stopped earlyThis early-phase study tested a treatment using donated natural killer (NK) cells from cord blood, combined with chemotherapy, for children and young adults with solid tumors that returned or didn't respond to standard care. The goal was to find the safest dose and check for side…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New cancer drug PRO1160 tested in advanced cancers – trial ends early
Disease control Stopped earlyThis study tested a drug called PRO1160 in people with advanced kidney cancer, nasopharyngeal cancer, or non-Hodgkin lymphoma. The goal was to find a safe dose and see if the drug shrinks tumors. The trial was stopped early, so results are limited.
Phase 1/2 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Asthma drug tested for stubborn nasal polyps – trial cut short
Disease control Stopped earlyThis phase 3 study tested the drug benralizumab in 295 adults with severe nasal polyps and eosinophilic chronic sinusitis. Participants received injections of benralizumab or a placebo every 4 to 8 weeks for about a year. The goal was to see if the drug could shrink polyps and im…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Experimental drug targets Hard-to-Treat cancers, but trial ends early
Disease control Stopped earlyThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer and other solid tumors that stopped responding to standard treatments. The goal was to see if the drug could shrink tumors or slow cancer growth. The trial was terminat…
Phase 2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Common diabetes and acne drugs studied for head and neck cancer treatment
Disease control Stopped earlyThis study tested whether metformin (a diabetes drug) and doxycycline (an antibiotic) could help treat head and neck cancer when taken before surgery. The trial aimed to see if these drugs could change certain proteins in the tumor's supportive tissue. Only 7 people took part bef…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental cancer drug TAK-500 tested in 61 patients – study halted early
Disease control Stopped earlyThis early-phase trial tested an experimental drug called TAK-500, alone or with the immunotherapy pembrolizumab, in 61 adults with advanced solid tumors like pancreatic, liver, and lung cancer. The main goals were to check safety and see if the drug could shrink tumors. The stud…
Phase 1/2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Cancer combo trial halted before full results
Disease control Stopped earlyThis early-stage trial tested a combination of two drugs, APG-1387 and toripalimab, in 40 people with advanced solid tumors including colorectal, nasopharyngeal, and lung cancers. The goal was to find a safe dose and see if the combination could control the disease. However, the …
Phase 1/2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Peptide vaccine shows promise in head and neck cancer trial
Disease control Stopped earlyThis study tested a peptide-based immunotherapy in 17 people with head and neck cancer who were scheduled for surgery. The goal was to see if the vaccine could boost the immune system's attack on cancer cells and to check for side effects. The trial was stopped early, but the res…
Phase 2 • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New laryngeal pacemaker aims to restore breathing in vocal cord paralysis
Disease control Stopped earlyThis study tested a device called the SPIRION Laryngeal Pacemaker in 10 people with bilateral vocal cord paralysis who had prior vocal fold surgery. The device is implanted to help open the vocal cords during breathing. Researchers checked if it was safe and if it improved breath…
Sponsor: MED-EL Elektromedizinische Geräte GesmbH • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Custom-grown ear implant tracked for long-term safety and looks
Disease control Stopped earlyThis study followed one person with microtia (a small or missing outer ear) who had already received an AUR-201 implant — a 3D-printed ear made from their own cartilage cells. Researchers checked how well the implant kept its shape and whether any side effects appeared up to 96 w…
Phase 1/2 • Sponsor: Auregen Biotherapeutics, SA • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
3D-Printed ear implant made from your own cells tested in tiny trial
Disease control Stopped earlyThis trial tested a new ear implant called AUR-201 for people with a rare birth defect called microtia, where one ear is small or missing. The implant was custom-made using the patient's own cartilage cells and a 3D-printed scaffold. Only 3 people were enrolled before the study w…
Phase 1/2 • Sponsor: Auregen Biotherapeutics, SA • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Experimental ear implant tested in tiny study
Disease control Stopped earlyThis study tested an experimental implant called AUR-201 to rebuild the outer ear in people with unilateral microtia (one ear that is small or missing). Only 2 people enrolled before the study was stopped early. The goal was to check safety and see if the implant improved ear app…
Phase 1 • Sponsor: Auregen Biotherapeutics, SA • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Experimental cancer drug INCB062079 tested in early trial
Disease control Stopped earlyThis early-phase trial tested a new drug called INCB062079 in 25 people with advanced liver cancer and other solid tumors. The main goal was to check safety and find the best dose. The study was terminated early, so results are limited.
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Experimental cancer drug trial ends early
Disease control Stopped earlyThis early-stage study tested an experimental drug called INCB099318 in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it. The study was terminated early, so results are…
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Cancer drug combo study halted early – only 15 patients enrolled
Disease control Stopped earlyThis study looked at whether adding the immunotherapy drug nivolumab to standard chemotherapy could help people with nasopharyngeal cancer that has returned or spread. The trial was planned for many participants but was stopped early, so only 15 people took part. Because of the e…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden oral cancer cells
Diagnosis Stopped earlyThis study tested a dye called tozuleristide that makes oral cancer cells glow under special light during surgery. The goal was to help surgeons see and remove all cancer while sparing healthy tissue. The trial included 8 adults with oral cavity cancer or high-grade dysplasia. Th…
Phase 1/2 • Sponsor: University of Washington • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
New imaging tool could help surgeons spot invisible oral cancers
Diagnosis Stopped earlyThis study tested whether a special imaging technique called narrow band imaging (NBI) can help surgeons find early cancer spots in the mouth that are not visible under normal light. The trial involved 23 people with oral cancer who were already scheduled for surgery. Doctors com…
Phase 2 • Sponsor: Centre Oscar Lambret • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Numbing ear drops could ease children's ear infection pain faster
Symptom relief Stopped earlyThis trial tests whether adding lidocaine ear drops to standard painkillers provides better ear pain relief for children aged 1–6 with acute otitis media. Half the children receive the ear drops plus usual care (oral painkillers, with or without antibiotics), while the other half…
Phase 3 • Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New sedative could speed recovery for ventilator patients
Symptom relief Stopped earlyThis study tests a new sedative called remimazolam for people in the ICU who need a breathing tube after oral or facial surgery. It compares remimazolam to two standard sedatives, propofol and midazolam, to see if it works just as well and helps patients wake up faster. The trial…
Phase 4 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Balloon treatment for sinusitis may offer faster recovery and less pain
Symptom relief Stopped earlyThis study compared a newer, less invasive procedure called balloon sinuplasty to standard surgery for people with frontal sinusitis that did not improve with medication. The balloon procedure uses a small catheter to open blocked sinus passages, aiming to reduce pain, bleeding, …
Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New stent aims to dry up tears after eye surgery
Symptom relief Stopped earlyThis study tested a redesigned lacrimal stent, called the Slit Stent II, for people with severe tearing (epiphora) caused by a blocked tear duct. The stent has slits to allow tears to drain while it is still in place after DCR surgery. The trial planned to enroll 5 people to chec…
Sponsor: Thomas Gardner • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Hay fever education trial fizzles out: did extra lessons help?
Symptom relief Stopped earlyThis study tested whether teaching teens and young adults (ages 14-29) the correct way to use nasal sprays for hay fever would improve their symptoms compared to standard care. The trial was terminated early and enrolled only 18 participants. The goal was to see if repeat educati…
Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can a simple nasal device boost mood and ease congestion?
Symptom relief Stopped earlyThis study tested whether using the SinuSonic device—a handheld tool that uses sound and gentle pressure to relieve nasal congestion—could also improve anxiety, depression, and overall well-being in adults with chronic stuffy nose. Sixteen participants used the device for 5 weeks…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Virtual reality could help pinpoint the perfect exercise dose for dizziness relief
Symptom relief Stopped earlyThis study aimed to find the best amount of exercise needed to improve dizziness symptoms in people with balance disorders. Researchers used virtual reality (VR) to measure how much exercise helps and compared VR exercises to standard physical therapy. The study included people w…
Sponsor: George Washington University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Experimental immune drug tested in HPV cancers – but trial halted early
Knowledge-focused Stopped earlyThis very early trial tested a single dose of HB-201 in 10 people with HPV 16+ throat or cervical cancer. The goal was to see how the drug affects the immune system, not to treat the cancer. The study was terminated early, so results are limited.
Early phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Preterm Kids' lungs under the microscope: study halted early
Knowledge-focused Stopped earlyThis study aimed to track lung function in children born prematurely (before 37 weeks) aged 3 to 5 years, comparing them to full-term children. Researchers used breathing tests and samples to look for early signs of asthma and allergies. The study was terminated early, so results…
Sponsor: Stefania La Grutta, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Study probes why patients delay throat cancer diagnosis
Knowledge-focused Stopped earlyThis study looked at why people with mouth or throat cancer wait before seeing a doctor. Researchers interviewed 90 patients and asked them to fill out questionnaires about their feelings, thoughts, and social situation. The goal was to understand what factors cause the delay, so…
Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
MRI scans aim to uncover hidden ear damage in CMV survivors
Knowledge-focused Stopped earlyThis study looked at whether people born with cytomegalovirus (CMV) infection who have hearing loss or balance problems also have a condition called endolymphatic hydrops (fluid buildup in the inner ear). Researchers used a special MRI scan with a contrast dye to check for this f…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Virtual implants may save jawbone during cancer radiation
Knowledge-focused Stopped earlyThis study tested a new planning method to protect areas where dental implants could later be placed in patients receiving radiation for head and neck cancer. Researchers used virtual implant markers on CT scans to adjust radiation doses, aiming to keep implant sites safe without…
Sponsor: Institut de cancérologie Strasbourg Europe • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC